Turkey Healthcare Infrastructure Investment & Finance Summit 2011

24 - 25 February 2011, Istanbul, Turkey.
The Turkish health system is in transition. As a part of the government's Health Transformation Programme, institutional and organizational reforms are underway that aim to assure universal access to health insurance and health services. Considering Medical Tourism, Turkey is on the rise. It was recently estimated by Turkish Statistical Institute that recently, there were 165,000 visitors to the country for healthcare and that they brought the country around $360 million USD.

From the series of Euroconvention's healthcare events, the Turkey Healthcare Infrastructure Investment & Finance Summit will bring together interested companies, financial institutions and government representatives with financeable healthcare projects in the region and will explore the critical issues for successful development and structuring of public-private partnerships (PPP) and private equity healthcare infrastructure investments across the region.

Taking a practical approach, the Summit will enable attendees and speakers to explore key issues, network and build personal relationships with key business and political decision-makers and to explore business opportunities in the development of healthcare infrastructure investment. The main themes will focus on recent trends and current needs in the Turkish healthcare infrastructure industry, PPP opportunities and challenges, the Turkish Health Transformation Programme and its development, joint investment opportunities in the region, while, similarly, we will highlight issues related to med-tech development, new medical technology, project development and e-health opportunities. Moreover, as Medical Wellness Tourism is on the rise and more and more accessible for foreigners in the region, the discussions will be similarly dedicated to the new market trends in wellbeing ventures.

The 200+ expected audience will consist of leading European, US and Middle East-based companies; large SMEs; technology-based companies, facility designers and constructors; trade financiers, investment officers, private equity investors, financial officers, legal firms, consulting and engineering companies, insurers, export credit agencies, multilateral institutions, financial institutions and PPP practitioners; central, regional and local Government Officials, etc.

For more information about speaking, sponsoring or attending opportunities, please visit:
http://www.euroconvention.com/events.php?action=details&event_id=48

About Euroconvention Conferences
Euroconvention Conferences is an independent Body which was set-up in 1987. It has been collaborating over the years with the European Commission and most of the International Financial Institutions, on some of the major matters related to the EU economical and financial integration like the ECU and later on the EURO, the Enlargement process and the EUmediterranean co-operation.

The Head Office is based in Brussels, with a rep-office in London. Since the late 1980s, it has organised events in more than 25 countries.

Most Popular Now

AI Language Models Write Good Doctor…

Generative AI should be able to write usable doctor's letters and thus potentially speed up medical documentation, according to a study by the University Medical Center Freiburg. Around 93% of...

West Yorkshire and Harrogate Hospitals S…

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out...

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

AI Drives Development of Cancer Fighting…

University of Houston researchers and their students are developing a new software technology, based on artificial intelligence, for advancing cell-based immunotherapy to treat cancer and other diseases. CellChorus...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Revolutionizing Cardiovascular Risk Asse…

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology. Led by Lama Al-Aswad, Professor of Ophthalmology and Irene Heinz...

HWL 2024 Brings Together a Record Number…

1 - 2 October 2024, Luxembourg. The second edition of Healthcare Week Luxembourg on 1 and 2 October 2024, organised by the Federation of Luxembourg Hospitals (FHL), in partnership with the...

Why the NHS Needs a Transparency Revolut…

Opinion Article by Dr Mark Ratnarajah, NHS paediatrician and UK Managing Director for C2-Ai. Wes Streeting wanted 'no stone left unturned' when he asked Lord Darzi to examine the current state...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...